Study to evaluate the safety and performance of the Innovalve mitral valve replacement system
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Innovalve TMVR system
Number of patients with implant or delivery related serious adverse events at 30 days
Number of patients with implant or delivery related serious adverse events at 30 days
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.